Who Exports Raltegravir from India — 29 Suppliers Behind a $6.4M Market

Hyderabad, often referred to as the "Bulk Drug Capital of India," hosts over 800 pharmaceutical companies, including major players like Dr. Reddy’s Laboratories and Aurobindo Pharma. The city is renowned for its production of active pharmaceutical ingredients (APIs), vaccines, biologics, and biosimilars. The presence of Genome Valley, India's first biotech cluster, along with advanced R&D infrastructure and a skilled talent pool from institutions like the National Institute of Pharmaceutical Education and Research (NIPER), positions Hyderabad as a pivotal hub for pharmaceutical manufacturing and innovation.

The Ahmedabad-Vadodara corridor in Gujarat is a significant center for pharmaceutical formulations and API production. Gujarat contributes nearly 28% of India's pharmaceutical production, with Ahmedabad and Vadodara housing major companies such as Zydus Cadila, Intas Pharmaceuticals, and Cadila Pharmaceuticals. The region's robust infrastructure, including well-developed ports and transportation networks, facilitates efficient export operations. Additionally, the presence of numerous pharmaceutical units underscores the area's capacity for large-scale manufacturing.

The Mumbai-Thane-Raigad belt serves as a strategic export gateway for India's pharmaceutical industry. Mumbai, being the financial capital, hosts the headquarters of several leading pharmaceutical companies, providing access to financiers, regulators, and global partners. The region's proximity to major ports like Nhava Sheva enhances its export capabilities. While land costs are higher, many firms maintain manufacturing units in other regions while centralizing operations in this corridor to leverage its logistical advantages.

Baddi-Nalagarh in Himachal Pradesh has emerged as a prominent pharmaceutical manufacturing hub, housing over 1,000 pharma companies. The region's growth was significantly influenced by favorable government policies, including tax incentives and excise duty exemptions, which attracted numerous pharmaceutical manufacturers. Baddi's strategic location near Chandigarh and its well-developed infrastructure have further contributed to its status as a major center for pharmaceutical production.

• Diversify Supplier Base: Given that the top two suppliers—HETERO LABS LIMITED and TITAN LABORATORIES PRIVATE LIMITED—account for over 90% of Raltegravir exports, it's advisable to explore partnerships with other manufacturers to mitigate supply chain risks.

• Leverage Regional Strengths: Consider sourcing APIs from Hyderabad due to its established bulk drug manufacturing capabilities, while utilizing the Ahmedabad-Vadodara region for formulations, capitalizing on their respective specializations.

• Optimize Export Logistics: Utilize the Mumbai-Thane-Raigad corridor for export operations to benefit from its proximity to major ports and established export infrastructure.

• Monitor Regulatory Compliance: Ensure that all suppliers adhere to international quality standards and regulatory requirements to maintain product integrity and facilitate smooth market entry.